RIL
LUCD icon

Rothschild Investment LLC’s Lucid Diagnostics LUCD Stock Holding History

Rothschild Investment LLC’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311 Buy
291
+270
+1,286% +$291 ﹤0.01% 3362
2026
Q1 		$24 Buy
+21
New +$27 ﹤0.01% 3528

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Rothschild Investment LLC's LUCD Position: Q2 2026 in Review

Rothschild Investment LLC increased its Lucid Diagnostics (LUCD) stake by 1,286% in Q2 2026, buying an estimated $291 and bringing the position to 291 shares worth $311. The position accounts for ﹤0.01% of the portfolio, ranked #3362.

Rothschild Investment LLC first reported a position in LUCD in Q1 2026 and has held it in 2 quarters since. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Rothschild Investment LLC held 291 shares of Lucid Diagnostics worth $311 as of Q2 2026.
  • Rothschild Investment LLC bought 270 Lucid Diagnostics shares in Q2 2026, an estimated $291.
  • Lucid Diagnostics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3362 holding.
  • Rothschild Investment LLC first reported a position in Lucid Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.